NCT02113020View on ClinicalTrials.gov

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Clinical Pharmacology
Interventions
DRUG

TAK-233

Oral administration of TAK-233

DRUG

Placebo

Oral admininstration of Placebo

Trial Locations (1)

Unknown

Kumamoto

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02113020 - A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects | Biotech Hunter | Biotech Hunter